Usted buscó: pertechnetate (Inglés - Maltés)

reconstitute with sodium pertechnetate (99mtc) injection
irrikostitwixxi b'injezzjoni ta’ sodium pertechnetate (99mtc)

reconstitute with sodium pertechnetate (99mtc) injection.
irrikostitwixxi b' injezzjoni ta 'sodium pertechnetate (99mtc).

rehydrate with sterile, non-pyrogenic 99mtc na pertechnetate.
zid tc99m na pertechnetate sterili

for injection after radiolabelling with sodium pertechnetate (99mtc).
għall-injezzjoni wara r-radjutikkettar b’sodium pertechnetate (99mtc).

following reconstitution, 1 ml sodium pertechnetate [99mtc] is added.
wara, jizdiedu 1ml ta ’ sodium pertechnetate (tc99m).

radiolabelling is performed using freshly eluted sodium pertechnetate (99mtc).
radjutikketar għandu jsir b’sodium pertechnetate (99mtc) li jkun għadu kif ġie eluż.

additional label after reconstitution and radiolabelling with sodium pertechnetate (99mtc) solution
tikketta addizzjonali wara r-rikostituzzjoni u r-radjutikkettar b’soluzzjoni ta’ sodium pertechnetate (99mtc).

10 min after the addition of pertechnetate (99mtc) the solution is ready for injection.
10 min wara li tkun żidt il-pertechnetate (99mtc) is-soluzzjoni hi lesta għall-injezzjoni.

sodium pertechnetate (99mtc) solution for injection (ph.eur) is used for reconstitution.
għar-rikostituzzjoni jintuża sodium pertechnetate (99mtc) soluzzjoni għall-injezzjoni (ph.eur).

intradermal, subcutaneous, intratumoural, or peritumoural use after radiolabelling with sodium pertechnetate (99mtc).
użu minn ġol-ġilda, taħt il-ġilda, fit-tumur, jew madwar it-tumur wara r-radjutikkettar b’sodium pertechnetate (99mtc).

after reconstitution with sodium pertechnetate (99mtc) solution for injection, 99mtc-depreotide is formed.
wara r-rikostituzzjoni b’sodium pertechnetate (99mtc) soluzzjoni għall-injezzjoni, jiġi ffurmat 99mtc- depreotide.

history of hypersensitivity reaction to depreotide, any of the excipients of neospect or sodium pertechnetate (99mtc) solution for injection.
sensittività eċċessiva għas depreotide, xi sustanzi mhux attivi ta’ neospect jew għal sodium pertechnetate (99mtc) soluzzjoni għall-injezzjoni.

neospect should not be used in people who may be hypersensitive (allergic) to depreotide, sodium pertechnetate or any of the other ingredients.
neospect m’għandux jintuża fuq nies li huma sensittivi żżejjed (allerġiċi) għal depreotide, sodium pertechnetate jew għal xi sustanza oħra tiegħu.

after labelling with the radioactive sodium pertechnetate (99mtc) solution for injection, radiolabelled neospect will be injected before the scan is taken.
wara t-tikkettar bis-soluzzjoni radjuattiva għall-injezzjoni, sodium pertechnetate (99mtc), neospect radjutikkettat ikun injettat qabel ma tittieħed l-iskan.

do not use bacteriostatic sodium chloride solution for injection as a diluent for pertechnetate, because it might adversely affect the radiochemical purity and, hence, the biological distribution of the tracer.
tużax soluzzjoni għall- injezzjoni ta ’ sodium chloride batterjostatiku bħala dilwent għall - pertechnetate, għax jista 'jaffettwa b’ mod negattiv is- safa radjukimika u, għalhekk, id- distribuzzjoni bijoloġika tas- sustanza li qed tintraċċa.

before it is used, the powder in the vial which contains tilmanocept is mixed with another medicine called sodium pertechnetate to make a substance called technetium (99mtc) tilmanocept.
qabel ma jintuża, it-trab fil-kunjett li fih tilmanocept jitħallat ma’ mediċina oħra li tissejjaħ sodium pertechnetate biex tinħoloq sustanza li tissejjaħ technetium (99mtc) tilmanocept.

introduce the itlc-sg or rbm-1 paper strip immediately into the chromatography tank using forceps to avoid formation of pertechnetate (99mtc) due to oxygen.
daħħal l-istrippa tal-karta tal-itlc-sg jew rbm-1 minnufih ġot-tank tal-kromatografija permezz ta’ pinzetta sabiex tevita l-formazzjoni ta’ pertechnetate (99mtc) minħabba l-ossiġenu.

the imaging agent, technetium-99m leukoscan [technetium-99m sulesomab] is formed by reconstitution of the contents of the leukoscan vial with 0.5 ml sodium chloride for injection followed by the addition of 1100 mbq of sodium pertechnetate [99mtc] in 1 ml of sodium chloride for injection.
il-prodott biex jittiehdu r-ritratti, technetium-99m leukoscan (technetium-99m sulesomab) jigi wara li zzid 0.5 sodium chloride fil-fjala ta leukoscan u wara zzid 1100 mbq ta’ sodium pertechnetate (tc99m) f’1ml ta’ sodium chloride ghall-injezzjoni.